Inventiva S.A. (EPA:IVA)
France · Delayed Price · Currency is EUR 4.020
+0.095 (2.42%)
Jul 31, 2026, 11:53 AM CET
Inventiva Market Cap
Inventiva has a market cap or net worth of €927.4 million as of July 31, 2026. Its market cap has increased by 142.43% in one year.
Market Cap
927.40M
Enterprise Value
1.06B
Revenue
6.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.02
ChartMarket Cap Chart
Since February 15, 2017, Inventiva's market cap has increased from 134.55M to 927.40M, an increase of 589.29%. That is a compound annual growth rate of 22.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 928.58M | 23.22% |
| Dec 31, 2025 | 753.62M | 261.37% |
| Dec 31, 2024 | 208.54M | -1.39% |
| Dec 29, 2023 | 211.49M | 12.21% |
| Dec 30, 2022 | 188.49M | -60.71% |
| Dec 31, 2021 | 479.69M | 6.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 9.38B |
| Nanobiotix | 1.67B |
| MedinCell | 906.22M |
| DBV Technologies | 701.91M |
| Genfit | 660.32M |
| Valneva SE | 415.71M |
| Valerio Therapeutics Société anonyme | 373.09M |
| Transgene | 196.65M |